Acute kidney injury in patients with acute pancreatitis

Česká verzia

Authors: N. Petejová ^1,2; Arnošt Martínek ^1,2 ; V. Teplan ^1–4
Authors place of work: Interní klinika LF OU a FN Ostrava ¹; Katedra interních oborů, LF OU, Ostrava ²; Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F., a. s., Praha ³; Subkatedra nefrologie, Institut postgraduálního vzdělávání ve zdravotnictví, Praha ⁴
Published in the journal: Gastroent Hepatol 2018; 72(2): 134-142
Category: Chapters from internal medicine: Review Article
doi: https://doi.org/10.14735/amgh2018134

Akutní poškození ledvin je poměrně častým a závažným stavem v klinické medicíně, který může komplikovat primární chorobu pacienta v téměř všech medicínských oborech, hlavně však u kriticky nemocných pacientů hospitalizovaných na jednotce intenzivní péče.

Summary

Introduction:
Acute kidney injury is a common diagnosis in clinical practice, occurring in virtually all fields of medicine. Critically ill patients in intensive care units are especially prone to the development of acute kidney injury.

Backgrounds:
The pathophysiology of acute kidney injury in patients suffering from acute pancreatitis is a result of many simultaneous factors and mechanisms: release of pancreatic amylase from the injured pancreas with resulting impairment of renal microcirculation, hypoxemia, decrease in renal perfusion pressure due to abdominal compartment syndrome, intraabdominal hypertension and hypovolemia. Systemic inflammation also plays an important role in the pathophysiology of acute pancreatitis and acute kidney injury.

Aims:
Early diagnostic evaluation of pancreatitis severity, diagnosis of acute kidney injury and adequate preventive/therapeutic measures can help prevent disease progression to multiple organ dysfunction syndrome. The management of acute kidney injury in patients with acute pancreatitis should take into account the underlying disease as well as the need to support the renal function with or without use of renal replacement therapy or blood purification techniques.

Conclusion:
Early and adequate preventive and therapeutic measures can prolong patient survival, improve outcome and lead to the recovery of kidney function.

Key words:
pancreatitis – acute kidney injury – renal replacement therapy

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
13. 3. 2018

Accepted:
9. 4. 2018

Zdroje

1. Prakash J, Singh TB, Ghosh B et al. Changing epidemiology of community-acquired acute kidney injury in developing countries: analysis of 2405 cases in 26 years from eastern India. Clin Kidney J 2013; 6 (2): 150–155. doi: 10.1093/ckj/sfs178.

2. Shah SH, Mehta RL. Epidemiology of community acquired acute kidney injury. In: Ronco C, Bellomo R, Kellum JA. Critical care nephrology. 2nd ed. Philadelphia: Saunders Elsevier 2009: 83–86.

3. Zhou J, Li Y, Tang Y et al. Effect of acute kidney injury on mortality and hospital stay in patient with severe acute pancreatitis. Nephrol-ogy (Carlton) 2015; 20 (7): 485–491. doi: 10.1111/nep.12439.

4. Foster BR, Jensen KK, Bakis G et al. Revised Atlanta classification for acute pancreatitis: a pictorial essay. Radiographics 2016; 36 (3): 675–687. doi: 10.1148/rg.2016150097.

5. Chawla LS, Bellomo R, Bihorac A et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 2017; 13 (4): 241–257. doi: 10.1038/nrneph. 2017.2.

6. Sporek M, Gala-Błądzińska A, Dumnicka P et al. Urine NGAL is useful in the clinical evaluation of renal function in the early course of acute pancreatitis. Folia Med Cracov 2016; 56 (1): 13–25.

7. Petejova N, Martinek A. Acute kidney injury following acute pancreatitis: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013; 157 (2): 105–113. doi: 10.5507/bp.2013.048.

8. Haschek WM, Rousseaux CG, Wallig MA. Chapter 10 – Pancreas. In: Fundamentals of toxicologic pathology. 2nd ed. London: Elsevier 2009: 237–260.

9. Li H, Qian Z, Liu Z et al. Risk factors and outcome of acute renal failure in patients with severe acute pancreatitis. J Crit Care 2010; 25 (2): 225–229. doi: 10.1016/j.jcrc.2009.07.009.

10. Maxwell RA, Bell CM. Acute kidney injury in the critically ill. Surg Clin North Am 2017; 97 (6): 1399–1418. doi: 10.1016/j.suc.2017.07.004.

11. Fisher ND. Overwiew of the renin-angiotensin system. [online]. Available from: www.uptodate.com.

12. Ba Aqeel SH, Sanchez A, Batlle D. Angiotensinogen as a biomarker of acute kidney injury. Clin Kidney J 2017; 10 (6): 759–768. doi: 10.1093/ckj/sfx087.

13. De Waele JJ, De Laet I, Kirkpatrick AW. Intra-abdominal hypertension and abdominal compartment syndrome. Am J Kidney Dis 2011; 57 (1): 159–169. doi: 10.1053/j.ajkd.2010.08.034.

14. Rogers WK, Garcia L. Intraabdominal hypertension, abdominal compartment syndrome, and the open abdomen. Chest 2018; 153 (1): 238–250. doi: 10.1016/j.chest.2017.07.023.

15. Villa G, Samoni S, De Rosa S et al. The pathophysiological hypothesis of kidney damage during intra-abdominal hypertension. Front Physiol 2016; 7: 55. doi: 10.3389/fphys.2016.00055.

16. O‘Connor ME, Prowle JR. Fluid overload. Crit Care Clin 2015; 31 (4): 803–821. doi: 10.1016/j.ccc.2015.06.013.

17. Oiva J, Mustonen H, Kylänpää ML et al. Acute pancreatitis with organ dysfunction associates with abnormal blood lymphocyte signaling: controlled laboratory study. Crit Care 2010; 14 (6): R207. doi: 10.1186/cc9329.

18. Kuuliala K, Penttilä AK, Kaukonen KM et al. Signalling profiles of blood leucocytes in sepsis and in acute pancreatitis in relation to disease severity. Scand J Imunol 2018; 87 (2): 88–98. doi: 10.1111/sji.12630.

19. Wang Y, Fuentes HE, Attar BM et al. Evaluation of the prognostic value of neutrophil to lymphocyte ratio in patients with hypertriglyceridemia-induced pancreatitis. Pancreatology 2017; 17 (6): 893–897. doi: 10.1016/j.pan.2017.10. 001.

20. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter Suppl 2012; 2: 1–138.

21. Joannidis M, Druml W, Forni LG et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med 2017; 43 (6): 730–749. doi: 10.1007/s00134-017-4832-y.

22. De Waele JJ. Acute pancreatitis. Curr Opin Crit Care 2014; 20 (2): 189–195. doi: 10.1097/MCC.0000000000 000068.

23. Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia 2010; 65 (3): 283–293. doi: 10.1111/j.1365-2044. 2009.06228.x.

24. Teixeira C, Garzotto F, Piccinni P et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013; 17 (1): R14. doi: 10.1186/cc12 484.

25. Hong W, Lin S, Zippi M et al. Serum albumin is independently associated with persistent organ failure in acute pancreatitis. Can J Gastroenterol Hepatol 2017; 2017: 5297143. doi: 10.1155/2017/5297143.

26. Teplan V. Akutní poškození a selhání ledvin v klinické medicíně. 1. vyd. Praha: Grada publishing 2009: 428.

27. McClave SA, Taylor BE, Martindale RG et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition ( a. s.P.E.N.). JPEN J Parenter Enteral Nutr 2016; 40 (2): 159–211. doi: 10.1177/0148607115621863.

28. Roberts KM, Nahikian-Nelms M, Ukleja A et al. Nutritional aspects of acute pancreatitis. Gastroenterol Clin North Am 2018; 47 (1): 77–94. doi: 10.1016/j.gtc.2017.10.002.

29. Zadák Z. Výživa v intenzivní péči. 2. vyd. Praha: Grada Publishing 2008: 544–548.

30. Kroužecký A. Intermitentní hemodialýza v intenzivní péči. In: Novák I, Matějovič M, Černý V et al. Akutní selhání ledvin a eliminační techniky v intenzivní péči. Praha: Maxdorf 2008: 78–84.

31. Matějovič M. Kontinuální eliminační metody a sepse. In: Novák I, Matějovič M, Černý V. Akutní selhání ledvin a eliminační techniky v intenzivní péči. Praha: Maxdorf 2008: 78–84.

32. Honoré PM, De Waele E, Jacobs R et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif 2013; 35 (4): 279–284. doi: 10.1159/000350610.

33. Joglekar K, Brannick B, Kadaria D et al. Therapeutic plasmapheresis for hypertriglyceridemia-associated acute pancreatitis: case series and review of the literature. Ther Adv Endocrinol Metab 2017; 8 (4): 59–65. doi: 10.1177/204201 8817695449.

34. Gelrud A, Whitcomb DC. Hypertriglyceridemia-induced acute pancreatitis. [online]. Available from: https: //www.uptodate.com/contents/hypertriglyceridemia-induced-acute-pancreatitis.

35. Teplan V. Praktická nefrologie. 2. vyd. Praha: Grada Publishing 2006: 536.

36. Kogelmann K, Jarczak D, Scheller M et al. Hemoadsorption by CytoSorb in septic patients: a case series. Crit Care 2017; 21 (1): 74. doi: 10.1186/s13054-017-1662-9.

37. Petejova N, Martinek A. The basic principles of critical care nephrology. 1. vyd. New York: Nova Science Publishers 2018: 218.

38. Ronco C, Ferrari F, Ricci Z. Recovery after acute kidney injury: a new prognostic dimension of the syndrome. Am J Respir Crit Care Med 2017; 195 (6): 711–714. doi: 10.1164/rccm.201610-1971ED.

39. Bellomo R. Acute renal failure. Semin Respir Crit Care Med 2011; 32 (5): 639–650. doi: 10.1055/s-0031-1287872.